Living With NonMelanoma Skin Cancer Cleveland Clinic – Skin Cancer Education and Research Foundation
Your Resource for Skin Cancer Information
Related Articles
Advances in Cancer Immunotherapy: A Focus on Toxicity Management
Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of toxicity management.
2nd Annual ASPirE Benefit Dinner
Join us for a special evening! You’re invited to a benefit dinner dedicated to advancing the future of immunotherapy care. The evening celebrates our mission…
How an Expert Would Treat Her Own Metastatic Melanoma: an Update – Cancer Commons
Cancer patients often ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks Stanford University School of Medicine…
Germline Cancer Susceptibility in Individuals with Melanoma
Inherited melanoma is not rare: approximately 1 in 7 individuals with melanoma harbored clinically relevant hereditable cancer susceptibility in a prospective cross-sectional study, with 3…
Checkpoint NOW: Season 2: Episode 4: Adrenal Insufficiency- What patients need to know. on Apple Podcasts
Show Checkpoint NOW, Ep Season 2: Episode 4: Adrenal Insufficiency- What patients need to know. – Jul 7, 2024
Clinical and Immunologic Features of Germline Pathogenic Variant–Positive Patients with Melanoma
AbstractPurpose:. Malignant melanoma represents the most lethal skin cancer with germline predispositions thought to comprise 10% to 15% of all melanoma cases. No studies to…
Germline Cancer Susceptibility in Individuals with Melanoma
Inherited melanoma is not rare: approximately 1 in 7 individuals with melanoma harbored clinically relevant hereditable cancer susceptibility in a prospective cross-sectional study, with 3…
The Immune Related Adverse Events (irAE) Consortium – GHLF.org
Immunotherapy is an emerging treatment that gives hope to patients facing different types of cancer. It stimulates the body’s immune system to fight cancer cell
The Immune Related Adverse Events (irAE) Consortium – GHLF.org
Immunotherapy is an emerging treatment that gives hope to patients facing different types of cancer. It stimulates the body’s immune system to fight cancer cell
Immune Checkpoint Inhibitors and Venous Thromboembolism: The More Things Change…
Thieme E-Books & E-Journals